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Abstract
In continuation of our previous study, we show that phosphatidyl ethanolamine (PE) depletion affects, in addition to amino acid
transporters, activities of at least two other proton motive force (pmf)-driven transporters (Ura4p and Mal6p). For Can1p, we demonstrate that
the lack of PE results in a failure of the permease targeting to plasma membrane. Despite the pleiotropic effect of PE depletion, a specific role
of PE in secretion of a defined group of permeases can be distinguished. Pmf-driven transporters are more sensitive to the lack of PE than
other plasma membrane proteins. D 2002 Elsevier Science B.V. All rights reserved.
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Phosphatidyl ethanolamine (PE) has been recognized as a
non-bilayer lipid that evokes lateral pressure within mem-
branes resulting in stabilization of membrane proteins in
native conformations [1–3]. New insights into an additional
role of this phospholipid in membrane transport processes
were furnished by studies of the effect of PE on LacY
permease in E. coli [4]. PE was shown to be necessary for
the permease to couple transport with the electrochemical
proton gradient across the membrane [5]. In addition, both
in vivo and in vitro experimental evidence has been pre-
sented that PE acts as a molecular chaperone in the folding
of this polytopic membrane protein [5–7].
Yeast triple mutant of Saccharomyces cerevisiae,
RY200T, lacking all pathways for the biosynthesis of PE
(psd1, psd2, dpl1), is able to grow only in the presence of
ethanolamine. Its omission from the medium and replacing
by choline led to PE depletion of the cells which, however,
for a limited time period, retained the same viability,
exogenous and endogenous respiration and plasma mem-
brane ATPase activity as the control cells. On the other
hand, the PE depletion had a dramatic effect on the
accumulation of amino acids mediated by several distinct
amino acid transport systems (Gap1p, Can1p, Put4p). Under
the same conditions, the accumulation of hexoses mediated
by facilitated diffusion was unaffected [8].
Two main questions were addressed in the present work:
(1) Is the observed effect of PE depletion restricted to
amino acid transporters, or is this phospholipid required also
for other proton motive force (pmf)-driven transport systems
in the yeast plasma membrane?
(2) Is the observed decrease of amino acid accumulation
caused by a selective decrease in the synthesis of the
pertinent amino acid permeases or is the PE effect exerted
at some different step?
(1) Activities of two other transport systems in yeast
plasma membrane coupled to pmf were tested for their
dependence on PE in the triple mutant of S. cerevisiae
RY200T.
In yeast, the maltose transport system has been identified
as being pmf dependent. The gene that encodes the maltose
transporter is clustered with two other genes required for
maltose utilization—maltase and a transcription activator
(review Ref. [9]). Its expression is induced by maltose and
repressed by glucose. However, many laboratory strains are
unable to grow on maltose because they are deficient in the
regulatory genes of MAL loci. Consequently, they do not
express either the maltose transporter or maltase. Since this
was the case of the triple mutant, we transformed this strain
with a plasmid containing a complete MAL1 locus [10]. The
transformants were selected for their ability to grow on
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maltose and the initial rate of its transport was checked in
PE-containing (ethanolamine-grown) and PE-depleted
(choline-grown) cells. As shown in Fig. 1A, the accumu-
lation of radioactive label from maltose was reduced by a
factor of about 3 in PE-depleted cells as compared to PE-
containing cells. An even more drastic effect (more than a
20-fold decrease) upon PE depletion was observed on the
uptake of uracil (Fig. 1B) mediated by a specific proton
symporter encoded by FUR4 gene [11]. For comparison, the
effect of PE depletion on arginine accumulation by Can1p,
and a lack of the effect on glucose-derived radioactivity
accumulation in the same batches of cells, are shown in Fig.
1C and D, respectively.
(2) For a detailed study of the PE-depletion effect on
pmf-driven membrane processes, the specific arginine trans-
porter Can1p [12] was used as a representative of yeast
amino acid permeases.
For the sake of identification and quantification of
Can1p, CAN1 gene was cloned as a fusion product with
the biotinylation peptide of Klebsiella pneumoniae and 6His
tail. The fusion protein, Can1BioHisp, was proved to be
equally active as the original one (data not shown). After
expression in the triple mutant, the biotinylated permease
was detected by a streptavidin–horseradish peroxidase
conjugate. As shown in the Western blot analysis after
SDS-PAGE resolution in Fig. 2, the protein is equally
Fig. 1. Effect of PE depletion on activities of Mal6p, Ura4p, Can1p and Hxt1p measured as a substrate radioactivity accumulation in S. cerevisiae RY200T.
Cells were grown on ethanolamine or choline medium as described previously [8]. To aliquots of yeast suspensions of f 2 OD/ml, radioactive substrates were
added to final concentrations of 2 mM maltose (A), 50 AM uracil (B), 20 AM arginine (C) or 1 mM glucose (D). Samples were withdrawn at intervals, filtered
on 0.8 Am pore-size cellulose nitrate filters and washed. The radioactivity was determined by scintillation counting.
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expressed in PE-depleted and PE-containing cells; the
amounts of the protein both in whole cell extracts and in
total membrane fractions of choline- and ethanolamine-
grown cells did not significantly differ. To avoid the
possibility of misinterpretation due to possible different
biotinylation efficiency in PE-containing and PE-depleted
cells, the Can1BioHisp was also identified with the use of a
specific antibody against the 6His tail engineered at the C-
terminus of the Can1p construct. The same results as with
streptavidin used for Can1BioHisp identification were
obtained using anti-His antibody (Fig. 2B). The insignif-
icant differences in the amounts of protein identified with
the use of the two different antibodies do not correlate with
the drastic decrease of Can1BioHisp activity observed in the
corresponding cells (Fig. 1C).
If the total amount of permease in the cell membrane
fraction is independent of the PE presence, it can be
envisaged that the protein is either inactive in PE-depleted
cells and/or it is not targeted correctly to the plasma
membrane. The latter possibility was tested by fractionating
total cell membranes on equilibrium density gradient (12–
54% sucrose) according to the Ljungdahl Lab Protocol
(kindly provided by F. Gilstring, Stockholm). After centri-
fugation, aliquots of each individual fraction were analysed
for the presence of Can1pBioHisp and for the markers of
plasma membrane and membrane organelles. As docu-
mented in Fig. 3, the pattern of the Can1BioHisp distribu-
tion in individual sucrose fractions is completely different in
PE-containing and PE-depleted cells. The permease from
PE-containing cells co-localized with the plasma membrane
marker Pma1p, the plasma membrane ATPase, in the heavy
membrane fractions. In contrast, the permease produced in
PE-depleted cells was found in lighter fractions, where it co-
localized with organelles of the secretory pathway—ER and
Golgi apparatus—detected by specific membrane fraction
markers Shr3p and Anp1p, respectively. This clearly proves
that the dramatic decrease in arginine accumulation medi-
ated by Can1BioHisp in PE-depleted cells is primarily
caused by an inability of the permease to reach the plasma
membrane and, most obviously, by its being retained in the
organelles of the secretory pathway.
Can1p, like other amino acid permeases, is co-transla-
tionally inserted into the membrane of ER. To be subse-
quently delivered to the plasma membrane, it must be
properly folded in its native conformation and, with the
assistance of Shr3p, it has to be included into COPII coated
transport vesicles [13–15]. As suggested earlier [16] and
demonstrated recently for the general amino acid permease
Gap1p, Shr3p does not participate in the co-translational
insertion of amino acid permeases into ER [17].
PE in E. coli was shown to participate in a late step of
LacY conformational maturation. The critical folding steps
after membrane insertion are dependent on the interaction of
LacY with PE [5–7]. It can be envisaged that events
analogous to those occurring at the cell membrane of
prokaryotes do take place at the level of subcellular mem-
branes in eukaryotes. The PE is delivered to ER from
mitochondria and from the Golgi/vacuole compartment
(PE produced by phospatidyl serine decarboxylation medi-
ated by Psd1p and Psd2p, respectively [18,19]) and/or from
the Kennedy pathway [20] utilizing either external ethanol-
amine or ethanolamine–phosphate arriving from degrada-
Fig. 2. Western blot analysis of Can1BioHisp content in PE-containing or PE-depleted cells. Whole cell extracts from 2 106 cells or extracts from total
membrane fraction were prepared from PE-containing or PE-depleted cells by conventional methods. SDS-dissociated samples were subjected to SDS-PAGE
and Western blot analysis. Can1pBioHisp was detected by streptavidin–peroxidase conjugate (Amersham) (A) or by anti-His antibody (Quiagen) as the
primary, and by horseradish peroxidase-linked anti-mouse immunoglobulins (Sigma) as the secondary antibody (B). Enhanced chemiluminescence system
(ECL, Amersham) was used for visualization.
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tion of sphingolipids (includes Dpl1p) [21]. Similarly as
documented for LacY permease, proper Can1p folding
might be crucially dependent on the presence of PE. The
quality control machinery [22] would subsequently prevent
the misfolded protein from being delivered to the correct
place of its destination. Instead, it is retained in the compart-
ments of the secretory pathway and/or eventually, rerouted
for degradation into the vacuole [23,24].
Two other plasma membrane proteins were tested for
their secretion to the plasma membrane under PE depletion.
As shown previously and in this study, activities and total
amounts of Pma1p (H + –ATPase) and of a hexose trans-
porter (Hxtp1p) are considerably less affected. Under the
conditions used in this study (2% of glucose), the transport
of glucose is mediated exclusively by the low-affinity/high-
capacity transporter Hxt1p [25]. Though there was no
difference in the accumulation of radioactive label originat-
ing from glucose (Fig. 1D), the pattern of Hxt1p distribution
was slightly shifted toward lighter fractions in PE-depleted
cells (Fig. 3), indicating thus that the trafficking of the
protein toward the plasma membrane is somewhat impaired.
The distribution of Hxt1p along all the membrane fractions
(in contrast to distinct localization of other membrane
markers) has been also observed by E. Boles, Du¨sseldorf
(personal communication).
Plasma membrane ATPase is delivered to the cell surface
by the secretory pathway [26]. Its distribution pattern in the
membrane fractions from PE-depleted cells is, similarly as
found for Hxt1p, partially shifted from the plasma mem-
brane fractions toward the lighter ones (Fig. 3). All this
indicates that the complete lack of PE in yeast interferes, to
a certain degree, with the secretion of membrane proteins in
general, and may reflect different demands of different
nascent proteins for PE to undergo the complete secretion
procedure. A family of permeases, sharing as common
feature the coupling to pmf (amino acid permeases, Furp4p),
is affected most seriously. For Can1p, the reason might be
an incorrect folding of the permease in PE-less ER mem-
brane and its consequent arresting in the secretory organ-
elles. The Shr3p responsible for selective inclusion of amino
acid permeases into transport vesicles [14] is an integral
membrane component residing in ER membranes. It con-
tains four membrane spanning segments and therefore it
cannot be excluded that the PE depletion also affects Shr3p
proper folding and/or function, which eventually leads to
the same phenotype of Can1p retention in ER. This, how-
ever, would not explain the effect of PE depletion on Fur4p.
Requirement for PE is more stringent on nonfermentable
than on fermentable carbon sources. Very recently, an
essential role of PE was reported in the function of mito-
chondria-related processes in yeast [27] that is independent
of its commonly accepted ability to form hexagonal phase
structure [28]. The decreased amount of PE caused by
deletion of pds1p located in the mitochondrial membrane
Fig. 3. Fractionation of cell membranes. Total cell membranes prepared from PE-containing and PE-depleted cells were fractionated on stepwise sucrose
gradient (12–54%) by centrifugation for 3 h at 150,000 g (SW-41) at 4 jC. An aliquot of 30 Al of each fraction was dissociated in SDS sample buffer at 50 jC
for 5 min and resolved by SDS-PAGE and Western blot. The individual proteins were detected as above by the corresponding specific primary antibodies and by
peroxidase– immunoglobulin conjugates (Sigma). Can1BioHisp was identified by streptavidin–peroxidase conjugate.
M. Opekarova´ et al. / Biochimica et Biophysica Acta 1564 (2002) 9–1312
is not sufficient to support growth of psd1D cells on lactose
and at elevated temperatures [27,29]. The specific require-
ment for PE in psd1D, psd2D, dpl1D strain could not be
satisfied by phosphatidyl propanolamine, a structurally
related lipid capable of forming the hexagonal phase [29].
This indicates that the essential function of PE is independ-
ent of its ability to form hexagonal phase structure. Dis-
ruption of two pathways leading to PE synthesis (psd1p,
psd2p) results in an impairment of synthesis of glycosyl-
phosphatidylinositol-anchored proteins (Gas1p), while the
amount of carboxypeptidase and the activity of invertase are
not affected [27]. This double mutant, however, still con-
tains about 10–20% of PE (as compared to wild type)
resulting from sphingolipid catabolism [18].
Using the triple mutant (psd1D, psd2D, dpl1D) devoid of
all pathways leading to PE synthesis in endogenous metab-
olism, we show that the considerably decreased PE content
in these cells grown on ethanolamine (about 5% as com-
pared to the wild type) is sufficient to ensure the correct
targeting of several (if not the majority) plasma membrane
proteins. Further PE depletion caused by replacing the
external ethanolamine by choline, however, results in severe
defects in the traffic of a defined group of permeases to
plasma membrane.
Secretion of membrane proteins, the activities of which
are independent of the coupling to pmf, is considerably less
affected.
Despite the pleiotropic consequences of PE depletion for
an extended period of time, a primary specific effect on
delivery of a pmf-driven plasma membrane permease Can1p
can be distinguished. We demonstrated that the effect of PE
depletion is exerted already at the level of protein secretion
and/or targeting.
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